文献速递消化系统肿瘤

北欧结直肠癌筛查项目:组织、运行与质量指标的比较

Nordic colorectal cancer screening programmes: A comparison of organization, operation, and quality indicators.
PubMed 文献 · Eur J Cancer · 2025-04-22

该文通过北欧结直肠癌筛查网络汇总丹麦、芬兰、冰岛、挪威和瑞典五国资料,建立2014—2024年筛查实施时间线,比较筛查流程与质量指标监测及绩效标准;五国均采用粪便免疫化学检测(FIT)但实施策略和截断值不同,均监测腺瘤检出率(ADR)、结肠镜并发症率、锯齿状息肉检出、结肠镜后结直肠癌(PCCRC)率和间期癌率,部分质量指标监测仍有改进空间。

要点

  • 2014—2024年五国均实施FIT结直肠癌筛查,但实施策略和截断值不同。
  • 各国均考虑结肠镜资源采取逐步实施策略,但推进速度不同。
  • 五国均监测ADR、结肠镜并发症率、锯齿状息肉检出、PCCRC率和间期癌率。

核心结论

  • 该文可作为未来北欧跨国研究和比较研究的关键参考,各国差异或可作为未来研究中的自然实验。
  • 该概览显示部分质量指标监测可能存在改进空间,以促进所有北欧国家的质量改进工作。

研究设计与样本

  • 通过北欧结直肠癌筛查网络汇集丹麦、芬兰、冰岛、挪威和瑞典五国专家提供的筛查项目信息。
  • 建立描述各国先行试点研究与国家推广的时间线,并呈现各国筛查流程及质量指标监测与绩效标准。

主要发现

  • 2014—2024年五个北欧国家均实施基于粪便免疫化学检测(FIT)的结直肠癌筛查,但实施策略和截断值不同。
  • 所有国家均考虑结肠镜资源采用逐步实施策略,但推进速度不同。
  • 质量监测遵循欧洲推荐但存在一定差异,腺瘤检出率(ADR)、结肠镜并发症率、锯齿状息肉检出、结肠镜后结直肠癌(PCCRC)率和间期癌率均由所有国家监测。

关键数值与推荐

  • 五国均采用FIT作为结直肠癌筛查方法,但截断值不同。
  • 所有国家均监测ADR、结肠镜并发症率、锯齿状息肉检出、PCCRC率和间期癌率。
  • 质量监测总体遵循欧洲推荐,但具体绩效标准存在差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: While comparison studies are common in the Nordic countries, important differences need to be illuminated to understand the comparability of future studies within colorectal cancer (CRC) screening research. Therefore, a systematic overview of similarities and differences in the CRC screening programmes in Denmark, Finland, Iceland, Norway, and Sweden was conducted METHODS: Information from each country was gathered through the Nordic CRC screening network, which includes experts in CRC screening from the participating countries. A timeline describing preceding pilot studies and national roll-outs in all countries was established. Furthermore, the screening flow in each country and the quality indicator monitoring including performance standards were presented. RESULTS: During 2014-2024, all five Nordic countries implemented CRC screening using faecal immunochemical testing (FIT) but with different implementation strategies and cut-off values. Taking colonoscopy resources into account, gradual implementation strategies were used in all countries, but with different paces. Quality monitoring follows the European recommendations with some variation; however key performance indicators such as adenoma detection rates (ADR), colonoscopy complication rates, serrated polyp detection, post-colonoscopy CRC (PCCRC) rates, and interval cancer rates, are monitored by all countries. CONCLUSION: This paper may serve as a key reference for future research and comparison studies across the Nordic countries. The variation found in countries with similar health care systems might serve as natural experiments in future studies. Furthermore, this overview shows that there might be room for improvements in the monitoring of certain quality indicators to facilitate quality improvement efforts in all Nordic countries.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Jørgensen SF, Njor SH, Nevala A, et al. Nordic colorectal cancer screening programmes: A comparison of organization, operation, and quality indicators. Eur J Cancer. 2025. PMID: 40294475. doi:10.1016/j.ejca.2025.115444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。